Tuesday, November 19, 2024

FDA awards Mindbreeze InSpire Software Licenses contract

Mindbreeze has been awarded a 2-year $4M contract for its InSpire Software Licenses by the Food and Drug Administration. The contract was awarded using the GSA FSS.

Mindbreeze InSpire promises to connect all information from throughout the entire digital workplace and provides personalized views that support each different department.

Awardee Name: MINDBREEZE CORPORATION
Contract Duration: 24 months
Total Contract Value: $3,571,563.06
Action Obligation: $1,190,521.02
Funding Agency: FOOD AND DRUG ADMINISTRATION
Number of Bidders: 1
Award ID: 75F40120F80263

[related-post]

LEAVE A REPLY

Please enter your comment!
Please enter your name here

FedHealthIT Xtra – Find Out More!

Recent News

Don’t Miss A Thing

Jackie Gilbert
Jackie Gilbert
Jackie Gilbert is a Content Analyst for FedHealthIT and Author of 'Anything but COVID-19' on the Daily Take Newsletter for G2Xchange Health and FedCiv.

Subscribe to our mailing list

* indicates required